ராப்பபோர்ட் ஆசிரிய News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ராப்பபோர்ட் ஆசிரிய. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ராப்பபோர்ட் ஆசிரிய Today - Breaking & Trending Today

Pfizer-BioNTech's COVID-19 vaccine effective and safe for use among cancer patients


Pfizer-BioNTech’s COVID-19 vaccine effective and safe for use among cancer patients
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
“To our knowledge, this study is the first to prospectively characterize the serologic status, immunogenicity, and safety of the BNT162b2 vaccine in a cohort of patients with solid tumors who are receiving active anticancer therapies,” writes the team from the Rambam Health Care Campus, the Rappaport Faculty of Medicine, and the Technion-Integrated Cancer Center, in Haifa.
While the efficacy and safety profiles of COVID-19 vaccines have previously been demonstrated in phase 3 studies, the team says patients with cancer were not adequately represented in these trials. ....

Irit Ben Aharon , Sally Robertson , Rambam Health Care Campus , Cancer Center , Rappaport Faculty , Technion Integrated Cancer Center , Serologic Status , Toxic Effects , Patients Undergoing Treatment , Image Credit , சாலி ராபர்ட்சன் , புற்றுநோய் மையம் , ராப்பபோர்ட் ஆசிரிய , தொழில்நுட்பம் ஒருங்கிணைந்த புற்றுநோய் மையம் , நச்சு விளைவுகள் , படம் கடன் ,

OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board


OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board
USA - English
News provided by
Share this article
Share this article
BINYAMINA, Israel, Jan. 11, 2021 /PRNewswire/ OncoHost, global leader in host response profiling for improved personalized cancer therapy, announced today that renowned biologist and winner of The Nobel Prize in Chemistry, Professor Aaron Ciechanover, has joined the company s scientific advisory board.
We are delighted to have Professor Ciechanover, an eminent researcher and physician, join our team. His profound scientific knowledge in protein biology and fundamental discoveries in protein turnover that awarded him the 2004 Nobel Prize in Chemistry will be an invaluable contribution to our research efforts in identifying effective personalized cancer treatments, said Dr. Ofer Sharon, CEO of OncoHost. OncoHost s unique approach to host response analysis and our methods to overcome therapy resistance will be further impr ....

United States , H Efa , Aaaron Ciechanover , Ofer Sharon , Kellie Hanson , Prnewswire Oncohost , European Molecular Biology Organization , Albert Lasker Prize For Basic Medical Research , Chinese Academy Of Sciences , Israel Prize For Biological Research , Rappaport Technion Integrated Cancer Center , Israeli National Academy Of Sciences , National Academies Of Sciences , Israel Institute Of Technology , Nobel Prize , Professor Aaron Ciechanover , Professor Ciechanover , Lasker Prize , Basic Medical Research , Biological Research , Israeli National Academy , National Academies , Foreign Associate , Chinese Academy , Foreign Member , Rappaport Faculty ,